Check each claim against its experiments, reported results, scope, and stated limitations.Know what the science actually supports before you trust the answer.
Press Enter ↵ to start review
Explore by Goal
"Two possibilities exist: either we are alone in the Universe or we are not. Both are equally terrifying."
- Arthur C. Clarke
Quick Explanation
Copied
Anoikis review—what it gets right, and what to be skeptical about
Strong mechanistic backbone (as a concept review): The paper frames anoikis as detachment-triggered apoptosis with intrinsic/extrinsic caspase convergence, and emphasizes the central role of integrin–ECM survival signaling.
Cross-disease mapping is broad: It extends the anoikis framework into cancer metastasis plus cardiovascular/diabetes contexts, but—because it’s narrative—cross-model generalizations should be treated as hypothesis-generating rather than settled.
Long Explanation
Paper Review (Critical, Visual): "Anoikis: an emerging hallmark in health and diseases"
DOI: 10.1002/path.3000 • Article received/revised/accepted in 2011; published as a J Pathol article (via provided full text).
1) What the paper claims (condensed, falsification-friendly)
Core definition: Anoikis is programmed cell death triggered by loss or inappropriate adhesion to ECM, disrupting integrin ligation; it helps prevent detached cells from dysplastic colonization.
Mechanistic logic: Initiation/execution can proceed via intrinsic (mitochondrial) and extrinsic (death receptor) apoptosis pathways, converging on caspase activation and DNA fragmentation.
Resistance framing: Anoikis resistance arises when survival signaling from ECM/integrins (and growth factor receptor crosstalk) is maintained or rewired; the review highlights cancer-associated strategies like integrin switching, EMT, ROS-linked pro-survival signaling, and autophagy-related survival.
Disease extrapolation: It proposes that impaired/overwhelmed anoikis and ECM proteolysis can contribute to cardiovascular degenerative pathologies and diabetic vascular complications (as discussed in the review).
2) Visual synthesis: mechanistic “wiring diagram”
This schematic follows the review’s stated logic: detachment disrupting integrin ligation reduces survival signaling, allowing intrinsic and/or extrinsic apoptosis routes that converge on caspase activation; it also highlights that maintained/rewired pro-survival pathways can yield anoikis resistance.
The review does not generate primary datasets; it synthesizes prior mechanistic studies and includes disease contexts.
Because this is narrative synthesis, high reference count and mechanistic coverage do not guarantee causal certainty. Instead, they increase the chance the review spans key observations, while also increasing selection-bias risk typical of non-systematic reviews.
4) Mechanistic coverage (known vs inferred vs uncertain)
Known (directly asserted by the review as mechanistic logic)
A detachment/inappropriate ECM adhesion state disrupts integrin ligation and can trigger apoptosis (“anoikis”).
Intrinsic and extrinsic apoptosis routes are described as converging on caspase activation/execution.
Survival signaling from integrin/ECM contact suppresses the anoikis death program via multiple downstream nodes (e.g., PI3K/Akt, ERK described in the review).
Inferred (review-level synthesis that should be cell-context-specific)
The review’s list of “anoikis resistance strategies” (integrin switching, EMT, ROS-linked pro-survival signaling, autophagy) is mechanistically plausible, but its universality across tissues/cancer subtypes is not established as a unified rule; the review itself notes cell-type differences in pathway activation.
Uncertain / needs stronger triangulation
Generalization from multiple species and diverse model systems: this is inherent to narrative reviews spanning molecular/cell biology and disease settings. The review discusses both in vitro and in vivo contexts via cited literature, implying heterogeneity.
Therapeutic targeting claims: the review argues for network-targeted/combinatorial approaches conceptually (and highlights miRNA-related concepts like miR-200 family), but the review itself is not a clinical efficacy report.
5) Independent cross-checks (related reviews)
Below are adjacent review sources that align with (and/or complicate) the paper’s narrative emphasis on anoikis resistance in cancer.
• The 2025 BMC Cancer review situates anoikis resistance within metastasis-relevant contexts.
• The 2017 Cancer Cell review focuses on intravascular survival/extravasation; it complements the idea that survival during circulation is required for metastasis, which dovetails with resistance concepts.
• The 2013 Anatomical Record review explicitly links autophagy and anoikis resistance in solid tumors, reinforcing the mechanistic intersection emphasized in the 2012 anoikis review.
6) Critical appraisal (skeptical review)
Strengths
Clear conceptual scaffold: The review repeatedly ties detachment/inappropriate ECM adhesion to loss of survival signaling and apoptosis execution via intrinsic/extrinsic convergence.
Disease-connection intuition: The cardiovascular/diabetes discussion uses ECM proteolysis and ECM modification logic to connect to cell detachment and anoikis.
Limitations & blind spots (as a narrative synthesis)
Selection bias risk: Narrative reviews depend on what was selected to include and what was not; the paper’s broad sweep raises the probability that some pathways are over-emphasized relative to their true effect size across contexts.
Heterogeneity limits universality: The review explicitly notes that cells from different tissue origins may activate dissimilar pathways leading to anoikis—so “one pathway to rule all” is not justified from the text alone.
Therapeutic inference is conceptual: The concluding remarks argue for network-targeted/combinatorial logic and miRNA-direction ideas, but the review does not provide quantitative therapeutic outcomes to adjudicate which nodes are most causally upstream in vivo.
What would most strongly disprove/reshape the narrative?
Context-specific dissociation: Demonstrating that key “hub” modules (as framed in the review) are not necessary for detachment-induced apoptosis in relevant primary tissues/cell states would weaken universality claims—even if mechanistic plausibility remains for some contexts.
Quantitative reassessment: Because the review is not a systematic meta-analysis, robust effect-size ranking across pathways (EMT vs ROS vs autophagy vs other survival routes) is not settled by the review alone.
7) Author-driven figures included in the provided text (what they add)
The provided paper text includes multiple conceptual figures (activation of anoikis pathways; integrin survival cascades; metastatic dissemination via resistance; acquisition of resistance strategies). These act as mechanistic maps rather than quantitative results.
This plot is a coverage map of conceptual modules emphasized by the review’s figure captions, not a quantitative measurement.
8) Next-step BGPT actions (bespoke research queries)
Author reviews (BGPT deep dives)
Feedback:
Updated: March 27, 2026
BGPT Paper Review
Study Novelty
70%
The review synthesizes established apoptosis/ECM–integrin signaling into a broad “anoikis as emerging hallmark” disease framing; novelty lies mainly in integration breadth and resistance-strategy mapping rather than introducing a wholly new mechanism.
Scientific Quality
80%
Mechanistic structure is clear and internally consistent; however, as a narrative review it cannot resolve causal necessity/sufficiency across heterogeneous cell types, and quantitative prioritization of competing pathways is not provided.
Study Generality
80%
The framework is broadly applicable to detachment-driven apoptosis biology (ECM/integrin survival vs death) and extends to multiple disease domains, but the review itself notes context-dependent pathway differences that limit a single universal mechanism.
Study Usefulness
80%
It is highly useful as a mechanistic map for designing targeted, pathway-level hypotheses (intrinsic/extrinsic convergence; integrin survival suppression; resistance via EMT/ROS/autophagy), but it is not a data-driven ranking of which nodes matter most in specific patient/tissue contexts.
Study Reproducibility
40%
Because it is a narrative review without new methods, reproducibility is mainly about re-running the underlying evidence selection (not possible from the review alone) and standardizing heterogeneous experimental contexts across cited works.
Explanatory Depth
80%
It offers deep mechanistic explanation at the level of apoptotic pathway architecture and upstream survival/death regulation, though it remains a synthesis rather than a single unified mechanistic proof across contexts.
It will parse the review’s cited anoikis-resistance regulators into a gene-pathway table, then produce a prioritized module map by summarizing how each regulator is linked to intrinsic/extrinsic vs survival suppression across contexts, using the provided literature list.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
“Anoikis resistance is universal and driven mainly by EMT transcription factors.” Rejection reason: the review emphasizes cell-type differences and multiple distinct resistance strategies (integrin switching, ROS, autophagy), implying EMT cannot be the sole driver across contexts.
“Detachment-induced apoptosis always uses identical intrinsic/extrinsic dominance.” Rejection reason: intrinsic/extrinsic routes are described as possible, but the review explicitly states that pathway activation differs across cell types, weakening strict dominance invariance.
Explore by Goal
Quick Explanation
Long Explanation
Top Data Sources
Ask a Follow-Up
Key Insight
Keep Exploring
Analysis 
Hypothesis Graveyard
Potential Experiments
Discussion